Craig Michael Bowe

Title: Craig Michael Bowe: Innovator in Menin Inhibition

Introduction

Craig Michael Bowe is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of menin inhibitors. His work is crucial for advancing therapeutic options in various diseases.

Latest Patents

Craig holds a patent for "Crystalline forms of a menin inhibitor." This patent describes crystalline forms of (S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile or solvate thereof. This innovation represents a significant step forward in the development of targeted therapies.

Career Highlights

Craig is currently associated with Kura Oncology, Inc., where he continues to push the boundaries of cancer research. His work has been instrumental in the advancement of new treatment modalities that aim to improve patient outcomes.

Collaborations

Throughout his career, Craig has collaborated with esteemed colleagues such as Roger Paul Bakale and Dipanjan Sengupta. These partnerships have fostered a collaborative environment that enhances innovation and research productivity.

Conclusion

Craig Michael Bowe is a prominent figure in the field of medicinal chemistry, with a focus on menin inhibitors. His contributions through patents and collaborations are paving the way for future advancements in cancer treatment.